Fauci experienced COVID-19 rebound after taking one course of Paxlovid. After his symptoms returned with a vengeance, he took a second course, which experts believe could be triggering SARS-CoV-2 mutations and resistance. STORY AT-A-GLANCE The U.S. Centers for Disease Control and Prevention issued a warning about the potential for COVID-19 rebound after Paxlovid treatment
Dr. Anthony Fauci took Paxlovid for COVID-19, tested negative, then developed worsened symptoms, known as COVID-19 rebound; he then took a second course of the drug
People who take Paxlovid can still transmit COVID-19 to others, even if they’re asymptomatic
Two separate studies suggest Paxlovid is causing SARS-CoV-2 to mutate and develop resistance to the drug
Despite the many questions regarding Paxlovid’s association with rebound infections and mutations, Pfizer is moving ahead and seeking full approval of the drug from the FDA Pfizer’s Paxlovid was granted emergency use authorization to treat mild to moderate COVID-19 in December 2021.1 The drug consists of nirmatrelvir tablets — the antiviral component — and ritonavir tablets, which are intended to slow the breakdown of nirmatrelvir.2…